In tumor immunity, CD4 T cells can activate cytotoxic T lymphocytes (CTLs) through a variety of mechanisms to maintain and strengthen the antitumor response of CTLs, while the presence of infiltrating Tregs may be detrimental to the host defense against the tumor [25, 42]. This evidence concerns the gene CD4 and neoplasm.